Zobrazeno 1 - 9
of 9
pro vyhledávání: '"CAROLINE LOW"'
Autor:
Laura Tornatore, Annamaria Sandomenico, Domenico Raimondo, Caroline Low, Alberto Rocci, Cathy Tralau-Stewart, Daria Capece, Daniel D’Andrea, Marco Bua, Eileen Boyle, Mark van Duin, Pietro Zoppoli, Albert Jaxa-Chamiec, Anil K. Thotakura, Julian Dyson, Brian A. Walker, Antonio Leonardi, Angela Chambery, Christoph Driessen, Pieter Sonneveld, Gareth Morgan, Antonio Palumbo, Anna Tramontano, Amin Rahemtulla, Menotti Ruvo, Guido Franzoso
Publikováno v:
Cancer Cell
Summary Constitutive NF-κB signaling promotes survival in multiple myeloma (MM) and other cancers; however, current NF-κB-targeting strategies lack cancer cell specificity. Here, we identify the interaction between the NF-κB-regulated antiapoptoti
Autor:
Jason G. Cyster, K. Mark Ansel, Caroline Low, Christopher D.C. Allen, Nobutaka Fujii, Robin Lesley, Hirokazu Tamamura
Publikováno v:
Nature Immunology. 5:943-952
Germinal center (GC) dark and light zones segregate cells undergoing somatic hypermutation and antigen-driven selection, respectively, yet the factors guiding this organization are unknown. We report here that GC organization was absent from mice def
Autor:
Richard L. Proia, Guy Cinamon, Matthew J. Lesneski, Theresa T. Lu, Jason G. Cyster, Mehrdad Matloubian, Ying Xu, Caroline Low
Publikováno v:
Nature Immunology. 5:713-720
The factors directing marginal zone B cells to the splenic marginal zone are not well understood. Here we report that FTY720, a drug that targets sphingosine 1-phosphate (S1P) receptors, induced marginal zone B cell migration into follicles. Marginal
Autor:
Gary Park, John McLaughlin, Vadim Markovtsov, Andrea Reitsma, Donald G. Payan, Shuling Fang, Chian Liu, Kazuya Shimoda, Elizabeth Tonkin, Haruko Shimoda, Jason Romero, Marina Gelman, Takuya Matsunaga, Allan Torneros, Rajinder Singh, Caroline Low, Wayne Lang, Jeffrey Clough, Polly Pine, Somasekhar Bhamidipati, Stacey Siu, Kotaro Shide, Matt Duan, Takuro Kameda, Yasumichi Hitoshi
Publikováno v:
Blood. 117(25)
The activating mutations in JAK2 (including JAK2V617F) that have been described in patients with myeloproliferative neoplasms (MPNs) are linked directly to MPN pathogenesis. We developed R723, an orally bioavailable small molecule that inhibits JAK2
Autor:
FRANZOSO GUIDO, TORNATORE LAURA, ALBERT JAXA-CHAMIEC, SIMONA M. MONTI, CAROLINE LOW, CATHERINE TRALAU-STEWART, MENOTTI RUVO
Publikováno v:
PCT/GB2010/001970, Internazionale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::955bdb5b53827223544277d57caea1ff
http://www.cnr.it/prodotto/i/144484
http://www.cnr.it/prodotto/i/144484
Autor:
Caroline Low, Daniel Fourmy, Barret Kalindjian, Magali Foucaud, Esther Marco, Chantal Escrieut
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2008, 283 (51), pp.35860-8. ⟨10.1074/jbc.M805513200⟩
Journal of Biological Chemistry, 2008, 283 (51), pp.35860-8. ⟨10.1074/jbc.M805513200⟩
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2008, 283 (51), pp.35860-8. ⟨10.1074/jbc.M805513200⟩
Journal of Biological Chemistry, 2008, 283 (51), pp.35860-8. ⟨10.1074/jbc.M805513200⟩
International audience; Given the importance of G-protein-coupled receptors as pharmacological targets in medicine, efforts directed at the understanding the molecular mechanism by which pharmacological compounds regulate their activity is of paramou
Publikováno v:
BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)
Background Oesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcome
Externí odkaz:
https://doaj.org/article/51d6749b614a4e64a41c38496f2ba94e
Publikováno v:
Breast Cancer Research & Treatment; Oct2004, Vol. 87 Issue 3, p277-290, 14p